Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Growth100Percnton Nov 07, 2018 10:21pm
78 Views
Post# 28941433

RE:RE:RE:Up a tad

RE:RE:RE:Up a tadExodduss- 
-I have posted my expectations about CVR before and I hold firm that this could be a $5-10B company at some point in time.  And if the expected revenues go as planned it could happen sooner than later.

-Why do I think this?
Well with projected 3yr sales at 500M and a P/E of 2= 1B valuation and for this example lets say 200M outstanding shares...the SP would be $5.
I would expect the P/E to be much higher than 2.
Lets say its 5, which is not unrealistic, the SP would be $12.50
-I believe the growth of this company will last many many years before it tops out.
Also consider that after 3yrs the revenue from the replacement sensor pads will be more than the device itself.
-I don't think anyone on this planet has not been affected by stroke.
-As far as a buyout...I really don't see a benefit to any shareholder to sell the company with all it has going for it.
-BUT it all hinges on when it gets FDA approval.
-As far as how long I intend to hold...I wouldn't see any reason to sell with all the upside coming (all depending on your personal goals)
-10 bagger...after doing the math...you probably could add a zero on to that...
-the above example was only at 500M of revenue...it will be much more in time.

If anyone would like to add to this or correct me, please do.
Thanks for your time.
Bullboard Posts